Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eurofins Scientific SE | Mexico | Healthcare | Biotechnology & Medical Research | MX$206.14B | 33.3x | 0.76 | MX$1,061.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Mexico | Healthcare | Biotechnology & Medical Research | MX$188.43B | -3.8x | -0.11 | MX$503.70 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CRISPR Therapeutics AG | Mexico | Healthcare | Biotechnology & Medical Research | MX$68.48B | -11.4x | 0.07 | MX$900 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
FibroGen | Mexico | Healthcare | Biotechnology & Medical Research | MX$569.69M | -0.2x | -0 | MX$6 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |